Works matching IS 02704137 AND DT 2018 AND VI 78 AND IP 8

Results: 9

Issue Information.

Published in:: Prostate, 2018, v. 78, n. 8, p. 561, doi. 10.1002/pros.23524
Publication type:: Article

Repeat prostate biopsies prior to radical prostatectomy do not impact erectile function recovery and mid‐ to long‐term continence.

Published in:

Prostate, 2018, v. 78, n. 8, p. 631, doi. 10.1002/pros.23509

By:

Furrer, Marc A.;
Vilaseca, Antoni;
Corradi, Renato B.;
Boxler, Silvan;
Thalmann, George N.;
Nguyen, Daniel P.

Publication type:

Article

Detectable end of radiation prostate specific antigen assists in identifying men with unfavorable intermediate‐risk prostate cancer at high risk of distant recurrence and cancer‐specific mortality.

Published in:

Prostate, 2018, v. 78, n. 8, p. 623, doi. 10.1002/pros.23507

By:

Hayman, Jonathan;
Phillips, Ryan;
Chen, Di;
Perin, Jamie;
Narang, Amol K.;
Trieu, Janson;
Radwan, Noura;
Greco, Stephen;
Deville, Jr., Curtiland;
McNutt, Todd;
Song, Daniel Y.;
DeWeese, Theodore L.;
Tran, Phuoc T.

Publication type:

Article

MAGI2 is an independent predictor of biochemical recurrence in prostate cancer.

Published in:

Prostate, 2018, v. 78, n. 8, p. 616, doi. 10.1002/pros.23506

By:

David, Stephanie N.;
Arnold Egloff, Shanna A.;
Goyal, Rajen;
Clark, Peter E.;
Phillips, Sharon;
Gellert, Lan L.;
Hameed, Omar;
Giannico, Giovanna A.

Publication type:

Article

A comprehensive evaluation of <italic>CHEK2</italic> germline mutations in men with prostate cancer.

Published in:

Prostate, 2018, v. 78, n. 8, p. 607, doi. 10.1002/pros.23505

By:

Wu, Yishuo;
Yu, Hongjie;
Zheng, S. Lilly;
Na, Rong;
Mamawala, Mufaddal;
Landis, Tricia;
Wiley, Kathleen;
Petkewicz, Jacqueline;
Shah, Sameep;
Shi, Zhuqing;
Novakovic, Kristian;
McGuire, Michael;
Brendler, Charles B.;
Ding, Qiang;
Helfand, Brian T.;
Carter, H. Ballentine;
Cooney, Kathleen A.;
Isaacs, William B.;
Xu, Jianfeng

Publication type:

Article

Identification of an IL‐1‐induced gene expression pattern in AR<sup>+</sup> PCa cells that mimics the molecular phenotype of AR<sup>−</sup> PCa cells.

Published in:

Prostate, 2018, v. 78, n. 8, p. 595, doi. 10.1002/pros.23504

By:

Thomas‐Jardin, Shayna E.;
Kanchwala, Mohammed S.;
Jacob, Joan;
Merchant, Sana;
Meade, Rachel K.;
Gahnim, Nagham M.;
Nawas, Afshan F.;
Xing, Chao;
Delk, Nikki A.

Publication type:

Article

The composition of prostate core matrisome in vivo and in vitro unveiled by mass spectrometric analysis.

Published in:

Prostate, 2018, v. 78, n. 8, p. 583, doi. 10.1002/pros.23503

By:

Ojalill, Marjaana;
Rappu, Pekka;
Siljamäki, Elina;
Taimen, Pekka;
Boström, Peter;
Heino, Jyrki

Publication type:

Article

AR‐V7 in circulating tumor cells cluster as a predictive biomarker of abiraterone acetate and enzalutamide treatment in castration‐resistant prostate cancer patients.

Published in:

Prostate, 2018, v. 78, n. 8, p. 576, doi. 10.1002/pros.23501

By:

Okegawa, Takatsugu;
Ninomiya, Naoki;
Masuda, Kazuki;
Nakamura, Yu;
Tambo, Mitsuhiro;
Nutahara, Kikuo

Publication type:

Article

Exploring the oncoproteomic response of human prostate cancer to therapeutic radiation using data‐independent acquisition (DIA) mass spectrometry.

Published in:

Prostate, 2018, v. 78, n. 8, p. 563, doi. 10.1002/pros.23500

By:

Keam, Simon P.;
Gulati, Twishi;
Gamell, Cristina;
Caramia, Franco;
Huang, Cheng;
Schittenhelm, Ralf B.;
Kleifeld, Oded;
Neeson, Paul J.;
Haupt, Ygal;
Williams, Scott G.

Publication type:

Article